{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:57:09Z","timestamp":1770843429855,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10067-021-05931-0","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T04:16:34Z","timestamp":1632888994000},"page":"869-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-9095","authenticated-orcid":false,"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-9760","authenticated-orcid":false,"given":"Mariana","family":"Gonz\u00e1lez-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-3637","authenticated-orcid":false,"given":"Jes\u00fas D.","family":"Mel\u00e9ndez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-2848","authenticated-orcid":false,"given":"Eugenia M.","family":"Ramos-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-3734","authenticated-orcid":false,"given":"Olga G.","family":"Cant\u00fa-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-3633","authenticated-orcid":false,"given":"C\u00e9sar H.","family":"Guti\u00e9rrez-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-2109","authenticated-orcid":false,"given":"Dionicio A.","family":"Galarza-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"5931_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/1744666X.2019.1656526","volume":"15","author":"JA Snowden","year":"2019","unstructured":"Snowden JA, Badoglio M, Alexander T (2019) The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? An update on behalf of the EBMT autoimmune diseases working party. Expert Rev Clin Immunol 15:981\u2013985. https:\/\/doi.org\/10.1080\/1744666X.2019.1656526","journal-title":"Expert Rev Clin Immunol"},{"key":"5931_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/ard.55.3.149","volume":"55","author":"A Tyndall","year":"1996","unstructured":"Tyndall A, Gratwohl A (1996) Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 55:149\u2013151. https:\/\/doi.org\/10.1136\/ard.55.3.149","journal-title":"Ann Rheum Dis"},{"key":"5931_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3324\/haematol.2009.017038","volume":"95","author":"T Hugle","year":"2010","unstructured":"Hugle T, Daikeler T (2010) Stem cell transplantation for autoimmune diseases. Haematologica 95:185\u2013188. https:\/\/doi.org\/10.3324\/haematol.2009.017038","journal-title":"Haematologica"},{"key":"5931_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"D Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A et al (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on autoimmune diseases. Haematologica 95:284\u2013292. https:\/\/doi.org\/10.3324\/haematol.2009.013458","journal-title":"Haematologica"},{"key":"5931_CR5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.bbmt.2012.06.003","volume":"18","author":"MC Pasquini","year":"2012","unstructured":"Pasquini MC, Voltarelli J, Atkins HL et al (2012) Transplantation for autoimmune diseases in north and South America: a report of the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 18:1471\u20131478. https:\/\/doi.org\/10.1016\/j.bbmt.2012.06.003","journal-title":"Biol Blood Marrow Transplant"},{"key":"5931_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/BOR.0000000000000646","volume":"31","author":"C Drenkard","year":"2019","unstructured":"Drenkard C, Lim SS (2019) Update on lupus epidemiology: advancing health disparities research through the study of minority populations. Curr Opin Rheumatol 31:689\u2013696. https:\/\/doi.org\/10.1097\/BOR.0000000000000646","journal-title":"Curr Opin Rheumatol"},{"key":"5931_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.amjmed.2013.09.002","volume":"126","author":"JD Greenberg","year":"2013","unstructured":"Greenberg JD, Spruill TM, Shan Y et al (2013) Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. Am J Med 126:1089\u20131098. https:\/\/doi.org\/10.1016\/j.amjmed.2013.09.002","journal-title":"Am J Med"},{"key":"5931_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11926-003-0045-1","volume":"5","author":"JD Reveille","year":"2003","unstructured":"Reveille JD (2003) Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 5:160\u2013167. https:\/\/doi.org\/10.1007\/s11926-003-0045-1","journal-title":"Curr Rheumatol Rep"},{"key":"5931_CR9","doi-asserted-by":"publisher","unstructured":"Murrieta-\u00c1lvarez I, Cantero-Fortiz Y, Le\u00f3n-Pe\u00f1a AA et al (2021) The 1,000th transplant for multiple sclerosis and other autoimmune disorders at the HSCT-M\u00e9xico program: a myriad of experiences and knowledge. Front Neurol 12. https:\/\/doi.org\/10.3389\/fneur.2021.647425","DOI":"10.3389\/fneur.2021.647425"},{"key":"5931_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcyt.2020.01.002","volume":"22","author":"JC Jaime-P\u00e9rez","year":"2020","unstructured":"Jaime-P\u00e9rez JC, G\u00f3mez-Galaviz AC, Turrubiates-Hern\u00e1ndez GA et al (2020) Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant. Cytotherapy 22:144\u2013148. https:\/\/doi.org\/10.1016\/j.jcyt.2020.01.002","journal-title":"Cytotherapy"},{"key":"5931_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ctr.14114","volume":"34","author":"JC Jaime-P\u00e9rez","year":"2020","unstructured":"Jaime-P\u00e9rez JC, Turrubiates-Hern\u00e1ndez GA, L\u00f3pez-Silva LJ et al (2020) Early changes in IL-21, IL-22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: a proof of concept study. Clin Transpl 34:1\u20136. https:\/\/doi.org\/10.1111\/ctr.14114","journal-title":"Clin Transpl"},{"key":"5931_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1210\/jc.2015-2776","volume":"101","author":"OG Cant\u00fa-Rodr\u00edguez","year":"2016","unstructured":"Cant\u00fa-Rodr\u00edguez OG, Lavalle-Gonz\u00e1lez F, Herrera-Rojas M\u00c1 et al (2016) Long-term insulin independence in type 1 diabetes mellitus using a simplified autologous stem cell transplant. J Clin Endocrinol Metab 101:2141\u20132148. https:\/\/doi.org\/10.1210\/jc.2015-2776","journal-title":"J Clin Endocrinol Metab"},{"key":"5931_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","volume":"2","author":"JMF Silva","year":"2018","unstructured":"Silva JMF, Ladomenou F, Carpenter B et al (2018) Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2:777\u2013786. https:\/\/doi.org\/10.1182\/bloodadvances.2017014449","journal-title":"Blood Adv"},{"key":"5931_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ana.23784","volume":"73","author":"PJ Darlington","year":"2013","unstructured":"Darlington PJ, Touil T, Doucet J-S et al (2013) Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol 73:341\u2013354. https:\/\/doi.org\/10.1002\/ana.23784","journal-title":"Ann Neurol"},{"key":"5931_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","volume":"13","author":"JF Swart","year":"2017","unstructured":"Swart JF, Delemarre EM, van Wijk F et al (2017) Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol 13:244\u2013256. https:\/\/doi.org\/10.1038\/nrrheum.2017.7","journal-title":"Nat Rev Rheumatol"},{"key":"5931_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/ard.2003.017798","volume":"63","author":"IM De Kleer","year":"2004","unstructured":"De Kleer IM, Brinkman DMC, Ferster A et al (2004) Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 63:1318\u20131326. https:\/\/doi.org\/10.1136\/ard.2003.017798","journal-title":"Ann Rheum Dis"},{"key":"5931_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","volume":"44","author":"RJ Verburg","year":"2001","unstructured":"Verburg RJ, Kruize AA, van den Hoogen FHJ et al (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 44:754\u2013760. https:\/\/doi.org\/10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","journal-title":"Arthritis Rheum"},{"key":"5931_CR18","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore J, Brooks P, Milliken S et al (2002) A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 46:2301\u20132309. https:\/\/doi.org\/10.1002\/art.10495","journal-title":"Arthritis Rheum"},{"key":"5931_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21:1387\u20131394. https:\/\/doi.org\/10.1038\/sj.leu.2404683","journal-title":"Leukemia"},{"key":"5931_CR20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"},{"key":"5931_CR21","doi-asserted-by":"publisher","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","volume":"4","author":"V Smith","year":"2019","unstructured":"Smith V, Scir\u00e8 CA, Talarico R et al (2019) Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 4:e000782. https:\/\/doi.org\/10.1136\/rmdopen-2018-000782","journal-title":"RMD Open"},{"key":"5931_CR22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","volume":"79","author":"S van Bijnen","year":"2020","unstructured":"van Bijnen S, de Vries-Bouwstra J, van den Ende CH et al (2020) Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study. Ann Rheum Dis 79:1084\u20131089. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217058","journal-title":"Ann Rheum Dis"},{"key":"5931_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L et al (2006) Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. J Am Med Assoc 295:527\u2013535. https:\/\/doi.org\/10.1001\/jama.295.5.527","journal-title":"J Am Med Assoc"},{"key":"5931_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2141.2012.09122.x","volume":"157","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Pearce RM, Lee J et al (2012) Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009. Br J Haematol 157:742\u2013746. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09122.x","journal-title":"Br J Haematol"},{"key":"5931_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","volume":"42","author":"J Youssef","year":"2016","unstructured":"Youssef J, Novosad SA, Winthrop KL (2016) Infection risk and safety of corticosteroid use. Rheum Dis Clin N Am 42:157\u2013176. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.004","journal-title":"Rheum Dis Clin N Am"},{"key":"5931_CR26","doi-asserted-by":"publisher","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med 17:e1003432. https:\/\/doi.org\/10.1371\/journal.pmed.1003432","journal-title":"PLoS Med"},{"key":"5931_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/pr.2011.66","volume":"71","author":"A Tyndall","year":"2012","unstructured":"Tyndall A (2012) Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr Res 71:433\u2013438. https:\/\/doi.org\/10.1038\/pr.2011.66","journal-title":"Pediatr Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05931-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05931-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05931-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T03:08:28Z","timestamp":1645758508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05931-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5931"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05931-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Research Ethics Committee (approval number: HE21\u201300020), and all patients provided an informed consent in accordance with the Declaration of Helsinki of 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}